Lipaglyn TM : Stronger binding with PPAR-α as a result of 4 H-bonding sites as against only 2 H-bonding sites in the case of Fenofibrate Lipaglyn TM F
{"Image DocumentName": "Fenofibrate nM LipaglynTM nM", "Image ImageDescription": "LipaglynTM: \u2018A million times\u2019 more potent in activating PPAR-\uf061 than Fenofibrate. Test Compound. PPAR activation EC50. hPPAR-\u03b1. Fenofibrate nM. LipaglynTM nM. In vitro PPAR Agonistic activity in HepG2 Cells. LipaglynTM is \u2018A million times\u2019 more potent in activating PPAR-\uf061 than Fenofibrate, which is evident from EC-50 data.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}